These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE). Aydemir S; Kandula P Seizure; 2022 Jan; 94():126-128. PubMed ID: 34896815 [No Abstract] [Full Text] [Related]
4. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective? Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381 [TBL] [Abstract][Full Text] [Related]
5. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy. Perry MS Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US. Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546 [TBL] [Abstract][Full Text] [Related]
7. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy. Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682 [TBL] [Abstract][Full Text] [Related]
8. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101 [TBL] [Abstract][Full Text] [Related]
9. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy. Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531 [TBL] [Abstract][Full Text] [Related]
10. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy. Tanwir A; Szabó CÁ Epileptic Disord; 2022 Aug; 24(4):713-718. PubMed ID: 35770762 [TBL] [Abstract][Full Text] [Related]
11. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases. Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472 [TBL] [Abstract][Full Text] [Related]
12. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia. Neubauer D; Perković Benedik M; Osredkar D Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Golub V; Reddy DS Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center. Porcari GS; Fu C; Doll ED; Carter EG; Carson RP Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908 [TBL] [Abstract][Full Text] [Related]
15. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511 [TBL] [Abstract][Full Text] [Related]
16. Cannabidiol in treatment of refractory epileptic spasms: An open-label study. Herlopian A; Hess EJ; Barnett J; Geffrey AL; Pollack SF; Skirvin L; Bruno P; Sourbron J; Thiele EA Epilepsy Behav; 2020 May; 106():106988. PubMed ID: 32169600 [TBL] [Abstract][Full Text] [Related]
17. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult. Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094 [TBL] [Abstract][Full Text] [Related]
18. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients. Caraballo R; Valenzuela GR Seizure; 2021 Nov; 92():238-243. PubMed ID: 34624613 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of potassium bromide in the treatment of drug-resistant epilepsy: a case of new-onset refractory status epilepticus]. Takei J; Takei R; Nozuma S; Nakahara K; Watanabe O; Takashima H Rinsho Shinkeigaku; 2016 Nov; 56(11):759-763. PubMed ID: 27773903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]